Journal Highlight: Diagnostic Tools for COVID-19 | AIChE

You are here

Journal Highlight: Diagnostic Tools for COVID-19

September
2020

With a lack of effective medical treatments or vaccines for COVID-19, early identification and patient isolation has been the most effective means of disease management to slow the spread of the pandemic. In point-of-care (POC) diagnosis, a test is performed at the time and place of patient care to inform the treatment plan. An effective POC diagnostic tool for COVID-19 could address current diagnostic limitations and improve healthcare and quarantine efforts.

In the Bioengineering & Translational Medicine article “Current Diagnostic Tools for Coronaviruses — from Laboratory Diagnosis to POC Diagnosis for COVID-19” (https://doi.org/10.1002/btm2.10177), Chao-Min Cheng et al. review the current state of COVID-19 diagnostic tools and propose a POC assay that utilizes antibody, protein, and serum cytokine detection for accurate and versatile diagnosis.

Current laboratory diagnostic tools. One of the most significant challenges for clinicians has been distinguishing COVID-19 from other acute respiratory tract infections because of its wide range of symptoms. Currently, the gold-standard approach is real-time reverse transcriptase-polymerase chain reaction (qRT-PCR), which detects the presence of viral ribonucleic acid (RNA) from respiratory...

Would you like to access the complete CEP Article?

No problem. You just have to complete the following steps.

You have completed 0 of 2 steps.

  1. Log in

    You must be logged in to view this content. Log in now.

  2. AIChE Membership

    You must be an AIChE member to view this article. Join now.

Copyright Permissions 

Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.

Automatic layout